Rare Tumor Clinic: The University of California San Diego Moores Cancer Center Experience with a Precision Therapy Approach

BACKGROUND. Patients with rare tumors may lack approved treatments and clinical trial access. Although each rare tumor is uncommon, cumulatively they account for approximately 25% of cancers. We recently initiated a Rare Tumor Clinic that emphasized a precision medicine strategy. MATERIALS AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Shumei, Kurasaki, Kellie, Ikeda, Sadakatsu, Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2017
Materias:
Cancer Diagnostics and Molecular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813742/
https://www.ncbi.nlm.nih.gov/pubmed/29038235
http://dx.doi.org/10.1634/theoncologist.2017-0199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813742/
https://www.ncbi.nlm.nih.gov/pubmed/29038235
http://dx.doi.org/10.1634/theoncologist.2017-0199

Ejemplares similares